Cancer Outcomes in Patients with Type 2 Diabetes and Modifiable Differences in Vulnerable Populations
A special issue of Diabetology (ISSN 2673-4540).
Deadline for manuscript submissions: 20 November 2026 | Viewed by 424
Editor
Special Issue Information
Dear Colleagues,
We are pleased to announce a forthcoming Special Issue titled “Cancer Outcomes in Patients with Type 2 Diabetes and Modifiable Differences in Vulnerable Populations.” This issue aims to explore the complex interplay between Type 2 diabetes and cancer, focusing on disparities in outcomes among vulnerable groups and identifying modifiable factors that can improve prognosis and care.
We invite original research articles or meta-analyses addressing the following:
- Epidemiological links between Type 2 diabetes and cancer incidence or survival and novel methods for analysis of such data;
- Biological mechanisms underlying these associations;
- Health disparities and social determinants influencing cancer outcomes;
- Interventions targeting modifiable risk factors in high-risk populations.
Submissions should provide evidence-based insights that advance clinical practice and health equity. Accepted manuscripts will contribute to shaping strategies for better cancer care in diabetic populations worldwide.
Deadline for submission: 20 May 2026.
For detailed author guidelines and submission instructions, please visit: https://www.mdpi.com/journal/diabetology/instructions.
Prof. Dr. Mulugeta Gebregziabher
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diabetology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- type 2 diabetes
- cancer incidence and prevalence
- vulnerable populations
- risk factors
- social determinants of health
- survival
- prediction models
- genetic factors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
